fda glp-1 compounding enforcement september 2025 Why the Issued 30 Warning Letters to Telehealth Sites Marketing Compounded GLP-1s Compounded Semaglutide & Tirzepatide 2025:
Description
While some claims were dismissed or excluded from the MDL, most will continue under the consolidated litigation framework
You know, they're put on, you know, different medications
Discuss Dose Adjustments With a Healthcare Provider Not all GLP-1 fatigue has to be tolerated
Many patients start at a lower dose and gradually adjust over time to help the body adapt and optimize results
The drugs could produce huge benefits for people with obesity but also present a major cost challenge given the large percentage of the population that is eligible for them, the report said
